RVMD
Revolution Medicines Inc
200.90$
+0.5%
vs. previous close
Closing price · As of: Oct 7, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +5.4% | +27.2% | -6.7% | +1.8% | -3.3% | -4.5% | -13.2% | +26.3% | -30.9% | +15.8% | -14.1% | -87.3% | +759.2% | -19.9% | +20.3% | -63.2% | +356.8% | -54.2% | -45.5% | -100.0% | – | -100.0% | – | – | – | -100.0% | – | – | – | – | – | – | |
| – | – | +16.5% | -5.0% | +14.1% | +19.7% | -0.1% | +19.9% | +5.9% | +6.1% | +10.4% | +12.4% | +1.2% | +15.5% | +5.2% | +8.0% | +13.9% | -4.8% | +4.3% | -88.9% | +1,309.8% | +26.8% | -13.6% | -89.2% | +1,087.9% | +23.9% | +9.4% | -98.2% | – | – | -3.6% | – | – | |
| – | – | +27.2% | -6.7% | +1.8% | -3.3% | -4.5% | -13.2% | +26.3% | -30.9% | +15.8% | -14.1% | -87.3% | +759.2% | -19.9% | +20.3% | -63.2% | +356.8% | -54.2% | -45.5% | -2,917.3% | – | -16,005.8% | – | – | – | – | – | – | – | – | – | – | |
| – | – | +16.5% | -5.0% | +14.1% | +19.7% | -0.1% | +19.9% | +5.9% | +6.1% | +10.4% | +12.4% | +1.2% | +15.5% | +5.2% | +8.0% | +13.9% | -4.8% | +4.3% | +42.1% | +10.0% | +37.8% | -20.5% | +14.3% | +12.5% | +23.9% | +9.4% | +8.9% | +17.1% | +11.5% | +17.6% | +14.8% | – | |
| – | -31.2% | -37.0% | +12.8% | +13.9% | +34.1% | +24.2% | -1.5% | +4.9% | +9.1% | +14.5% | +9.4% | +6.8% | +11.6% | +4.0% | +12.9% | +2.3% | +4.6% | +21.2% | +10.7% | +6.0% | +107.9% | -29.2% | -4.9% | +10.4% | +17.8% | +24.1% | +15.9% | +30.0% | +21.9% | +57.4% | +8.9% | – | |
| – | – | +7.2% | -3.2% | +14.1% | +21.4% | +3.1% | +16.5% | +5.8% | +6.5% | +11.0% | +12.0% | +1.9% | +14.9% | +5.1% | +8.7% | +12.2% | -3.6% | +6.7% | +37.1% | +9.4% | +46.6% | -22.1% | +11.2% | +12.2% | +23.1% | +11.3% | +9.9% | +19.1% | +13.2% | +23.5% | +14.6% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | -9.1% | -6.7% | -10.7% | -8.0% | -8.7% | -9.5% | -10.5% | -17.6% | -14.3% | -100.0% | – | – | +1,158.3% | +187.1% | +235.3% | +10.4% | +198.9% | – | – | – | – | – | – | – | – | – | +1,171.2% | +4.4% | +2.2% | +95.0% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | -7.7% | +40.3% | +63.0% | -670.9% | – | – | – | +4.3% | -35.6% | +1.3% | -5.5% | -918.4% | – | – | – | – | – | – | – | – | -905.5% | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.